Scilex Holding Company Expands Distribution Reach Through Partnership with Endeavor Distribution

Strategic Insights -

Scilex Holding Company, a revenue-generating firm specializing in non-opioid pain management products, has formed a non-exclusive distribution agreement with Endeavor Distribution, a logistics expert with over 10 years of sales excellence. This partnership enables Scilex to expand its reach to new and current special customers, leveraging Endeavor's logistics expertise to nationally distribute its marketed non-opioid products. With over a decade of experience in logistics, warehousing, manufacturing, and customer service, Endeavor is well-positioned to provide top-notch logistics and distribution services to Scilex's clients. The agreement marks a significant step in Scilex's strategy to accelerate product growth and launch its commercial products into specialized point-of-care customers.

Key Takeaways:

  • Scilex Holding Company has entered into a non-exclusive distribution agreement with Endeavor Distribution, a logistics expert with over 10 years of sales excellence.
  • Endeavor Distribution has logistics expertise to sell and distribute Scilex's currently marketed non-opioid products nationally.
  • The partnership enables Scilex to expand its reach to new and current special customers and accelerate its product growth.
  • Scilex is aggressively implementing its strategy of building out additional logistics and distribution for its commercial products.
  • The company aims to continue refining its launch strategy and selectively add distribution partners who serve its shared customers with excellence.
  • Jaisim Shah, CEO and President of Scilex, emphasized the importance of the partnership in setting the stage for a successful and aggressive product launch into specialized point-of-care customers.
  • Scilex's commercialization of its three non-opioid products continues on schedule, with growth expected to accelerate through 2024.

Statistics:

  • Over 10 years of sales excellence for Endeavor Distribution.
  • Scilex's products will be nationally distributed through Endeavor Distribution.
  • Scilex has marketed three non-opioid products for the treatment of acute and chronic pain.
  • The company anticipates growth to accelerate through 2024.

Sources:

  • Scilex Holding Company press release.
  • Endeavor Distribution company profile.